1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
- Unreported exclusion and sampling bias in interpretation of randomized controlled trials in patients with STEMI
- Impact of Multiple Myocardial Scars Detected by CMR in Patients Following STEMI
- 2018
- Benefit From Reperfusion With Primary Percutaneous Coronary Intervention Beyond 12 Hours of Symptom Duration in Patients With ST-Segment-Elevation Myocardial Infarction
- Comparison between patients included in randomized controlled trials of ischemic heart disease and real-world data. A nationwide study